UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

BMC neurology, 2021-03, Vol.21 (1), p.126-126, Article 126

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

The Journal of pharmacology and experimental therapeutics, 2019-04, Vol.369 (1), p.26

2019

Link zum Volltext

Verfügbarkeit prüfen

Red Flags and Comfort Signs for Ominous Secondary Headaches

Otolaryngologic clinics of North America, 2014-04, Vol.47 (2), p.289-299

Cady, Roger K., MD

2014

Link zum Volltext

Verfügbarkeit prüfen

Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

Headache, 2006-01, Vol.46 (1), p.24-33

2006

Link zum Volltext

Verfügbarkeit prüfen

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study

Neurology, 2016-08, Vol.87 (5), p.529

2016

Link zum Volltext

Verfügbarkeit prüfen

Headache and Migraine Biology and Management

Seymour Diamond, Roger K. Cady, Merle L. Diamond, Mark W. Green, Vincent T. Martin

1, 2015

Link zum Volltext

Verfügbarkeit prüfen

Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Headache, 2008-07, Vol.48 (7), p.1012-1025

2008

Link zum Volltext

Verfügbarkeit prüfen

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Journal of the neurological sciences, 2013-08, Vol.331 (1), p.48-56

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy of a Double-Blind, Placebo-Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360® Device for Treatment of Chronic Migraine

Headache, 2015-04, Vol.55 (4), p.529-542

2015

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine

Headache, 2007-11, Vol.47 (10), p.1398-1408

2007

Link zum Volltext

Verfügbarkeit prüfen

Acupuncture in the Treatment of Headache: A Traditional Explanation of an Ancient Art

Headache, 2015-03, Vol.55 (3), p.457-464

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

Journal of headache and pain, 2017-12, Vol.18 (1), p.17-8, Article 17

2017

Link zum Volltext

Verfügbarkeit prüfen

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Headache, 2015-05, Vol.55 (5), p.621-635

2015

Link zum Volltext

Verfügbarkeit prüfen

Chronic migraine in women

The Journal of family practice, 2014-02, Vol.63 (2 Suppl), p.S46-S51

Cady, Roger K

2014

Link zum Volltext

Verfügbarkeit prüfen

AVP-825 Breath-Powered Intranasal Delivery System Containing 22mg Sumatriptan Powder vs 100mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Headache, 2015-05, Vol.55 (5), p.621-635

2015

Link zum Volltext

Verfügbarkeit prüfen

Managing migraine by patient profile: role of frovatriptan

Patient preference and adherence, 2016-01, Vol.10, p.501-510

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg

Clinical therapeutics, 2007, Vol.29 (11), p.2511-2519

2007

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

Headache, 2015-01, Vol.55 (1), p.88-100

2015

Link zum Volltext

Verfügbarkeit prüfen

A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine

Headache, 2011-01, Vol.51 (1), p.21-32

2011

Link zum Volltext

Verfügbarkeit prüfen

Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan

Headache, 2009-10, Vol.49 (9), p.1258-1266

2009

Link zum Volltext

Verfügbarkeit prüfen

The Convergence Hypothesis

Headache, 2007-04, Vol.47 (s1), p.S44-S51

Cady, Roger K.

2007

Link zum Volltext

Verfügbarkeit prüfen

A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesicTMM) in the Treatment of Migraine

Headache, 2011-07, Vol.51 (7), p.1078-1086

2011

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

Journal of headache and pain, 2017-12, Vol.18 (1), p.31-8, Article 31

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

Headache, 2008-10, Vol.48 (9), p.1326-1336

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Sumatriptan-Naproxen in the Treatment of Acute Migraine: A Placebo-Controlled, Double-Blind, Cross-Over Study Assessing Cognitive Function

Headache, 2013-04, Vol.53 (4), p.656-664

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(139)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(90)
Science & Technology
(87)
Life Sciences & Biomedicine
(86)
Migraine
(73)
Migraine Disorders - Drug Therapy
(63)
Female
(62)
Adult
(58)
Male
(54)
Neurosciences & Neurology
(53)
Clinical Neurology
(52)
Biological And Medical Sciences
(49)
Medical Sciences
(47)
Neurology
(44)
Middle Aged
(43)
Vascular Diseases And Vascular Malformations Of The Nervous System
(36)
Neurosciences
(35)
Pharmacology. Drug Treatments
(35)
Double-Blind Method
(31)
Cardiovascular System
(29)
Vasodilator Agents. Cerebral Vasodilators
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

Red Flags and Comfort Signs for Ominous Secondary Headaches

Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study

Headache and Migraine Biology and Management

Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Long-Term Efficacy of a Double-Blind, Placebo-Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360® Device for Treatment of Chronic Migraine

The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine

Acupuncture in the Treatment of Headache: A Traditional Explanation of an Ancient Art

Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Chronic migraine in women

AVP-825 Breath-Powered Intranasal Delivery System Containing 22mg Sumatriptan Powder vs 100mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Managing migraine by patient profile: role of frovatriptan

Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine

Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan

The Convergence Hypothesis

A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesicTMM) in the Treatment of Migraine

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

Evaluation of Sumatriptan-Naproxen in the Treatment of Acute Migraine: A Placebo-Controlled, Double-Blind, Cross-Over Study Assessing Cognitive Function

Suchergebnisse filtern